spacer
home > ict > Winter 2016
PUBLICATIONS

International Clinical Trials

ict
Winter 2016

   
Text
PDF
Editor's Comment

Graham Hughes welcomes the new year by highlighting a selection of articles from this edition, including regulatory updates, the increasing need for real world studies, and strategic partnerships.
 
view
download pdf
bullet
REGULATORY
Data Management

Done Deal


The much-anticipated General Data Protection Regulation is set to take effect in EU member states in 2018. Pete Chan at Tudor Reilly Health comments on some of the changes and voices concerns that these will not be sufficient enough.


 
view
download pdf
Regulatory Update

EU Clinical Trial Regulation: Be Prepared


Also introduced in 2018, the EU Clinical Trial Regulation will have sponsors preparing for this new legislative framework to maximise positive efficiencies and minimise burdens – according to NDA’s Olga Björklund and Dr Brian Edwards.


 
view
download pdf
Clinical Data

Trials and Tribulations

Sophie Pelé
at Dechert elaborates on the scientific and political benefits the publication of clinical trial patient data brings, and whether these can overcome legal risks.
 
view
download pdf
bullet
Clinical Trial Management
Real World Evidence

Chasing Reality


Jonathan Hart-Smith at CK Aspire talks about the growing demand for real world evidence studies in deciding on a clinical trial pathway, and discovers it supports the increasing needs of payers.
 
view
download pdf
Q&A: Oncology Research

Putting the Patient First


Inability to retain patients is the reason why almost half of oncology studies fail, CRF Health’s Jessica Thilaganathan tells ICT, and proposes electronic clinical outcome solutions as a remedy.
 
view
download pdf
Patient Recruitment

Take a Chance

Patient enrolment in clinical trials is taken to a new level by embracing a more digital approach, thus eliminating the need to rely on luck. Clare Jackson, Utku Ozdemir and Liz Moench at MediciGlobal outline the advantages this brings.
 
view
download pdf
bullet
Clinical Trial Supply & Packaging
Smart Thermal Packaging

Hot and Cold
 

Transporting temperature-sensitive drugs need not always be a challenge – using vacuum-insulated packaging and implementing selection criteria can enhance the cold chain, remarks Fabian Eschenbach at va-Q-tec.
 
view
download pdf
Q&A: Clinical Trial Logistics

Cold to the Touch

World Courier
’s Sue Lee reflects on the evolving developments and requirements in clinical trial logistics, and tells ICT about the move towards patient-centred processes and supplies.
 
view
download pdf
bullet
MARKETPLACE
Supply Efficiencies

The Power of Strategic Sourcing


Closer strategic partnerships between pharma companies, CROs and specialist comparator sourcing agencies are the result of increasing complexity and external drivers, states Clinigen Clinical Trial ServicesSteve Glass – thus bolstering efficiencies without compromising quality.
 
view
download pdf
2016 Predictions

All Things Digital


Abraham Gutman at AG Mednet predicts the upcoming technological advances of 2016, with a view towards moving closer to zero delays for clinical trials.
 
view
download pdf
End Point

Money Talks

Graham Hughes
examines the reasons for high drug prices – highlighting the differences among some countries – and what implications this has for the pharma industry.
 
view
download pdf
bullet
Central Labs
Biomarker Advances

Aim for the Top

Medpace
’s Paul Travis is convinced that biomarkers are the way forward for CROs wanting to keep up with the latest drug development trends and harness new technologies and regulations.


 
view
download pdf
Microbiological Labs

Driven by Results: Part 1


Quantitative urine culture studies can be challenging to conduct, particularly with microbiology labs under ever-increasing pressure to perform. Olga Sazonova, Veronika Khokhlova, Andrey Karelin and Maxim Belotserkovsky at PSI CRO present techniques for achieving optimal results in the first of a two-part article.
 
view
download pdf
bullet
Digital Advances
Q&A: Digital and Cloud Developments

A Step Ahead
 

Medidata’s Kara Dennis and Matt Noble discuss the latest digital advances – such as mHealth devices, patient-centric research, and innovative products like wearables, hearables and medical smart patches.
 
view
download pdf
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August, and November

News and Press Releases

The CPhI Annual Report

The global pharmaceutical landscape is evolving at an extraordinary pace as manufacturing capabilities, drug development technologies, and regulation advances creating new ways of innovating drugs and better serving patients.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>

Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement